chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a health professional concerning a 27 year old female with a history of migraines who on 15-AUG-2007 was vaccinated intramuscularly in the right deltoid with the first dose of Gardasil (Lot # 658100/0525U). She complained of a headache at that time. Concomitant therapy included norethindrone (MICRONOR) and rizatriptan benzoate (MAXALT (rizatriptan benzoate)) (as needed). On 16-AUG-2007 the patient experienced sore throat, pain in right neck, shoulder pain, fever (felt hot and cold), swollen lymph nodes, ear pain, dizziness and nausea. She called her primary physician who sent her to the emergency room, while there she had a fever and swollen lymph noes and the nausea and pain continued. She was treated with intravenous fluids for hydration to prevention serious criteria, and unnamed medications for nausea and pain. She was later released from the emergency room. Subsequently, the patient recovered from sore throat, was later released from the emergency room. Subsequently, the patient recovered from sore throat, pain in right neck, shoulder pain, fever, swollen lymph nodes, ear pain, dizziness and nausea. Additional information has been requested.
Tinnitus that developed on March 20, 2021 1 week after the second dose of Pfizer/BioNTech
Sore throat, headache, chills, sweats, itchy/burning eyes, feeling "off", nausea, diarrhea, lethargy, body aches  No treatment outside of home as of yet.  Hydration, rest, OTC cold/flu medications to help decrease symptoms.
Diarrhea; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of diarrhea in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced diarrhea (Verbatim: Diarrhea). The outcome of the diarrhea was not reported.   It was unknown if the reporter considered the diarrhea to be related to Shingles vaccine.     It was unknown if the company considered the diarrhea to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 09-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that he/she received second dose of Shingles vaccine and experienced some diarrhea. Follow-up would not possible as no contact details were available.
My mother had a stroke within 48 hours of her Covid vaccination. She was found more than 24 hours after the event and the hospital did not determine a cause. She was hospitalized for 4 days then transferred to rehab for 2.5 weeks and is now in ongoing out-patient care.
24 hours after recieving the vaccine, the patient had a spontaneous epsiode of limpness / unresponsiveness, cyanosis all over the body, not breathing. This lasted for approximately 2 minutes.  Parents revived the child.
This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (SHINGRIX) for prophylaxis. Previously administered products included SHINGRIX (1st dose received 2 years ago from reporting date).  On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown. Additional details were reported as follows: The patient self-reported this case. The age at vaccination was not applicable for this report. Till the time of reporting, the patient never got the 2nd dose of SHINGRIX, which led to incomplete course of vaccination. The follow-up would not possible as no contact details were available.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's current conditions, medical history and concomitant medications were not reported. On 31-MAR-2016, the patient was vaccinated with a dose of MMR II (lot # 1032181 and expiry date 25-AUG-2017) and a dose of (Oka-Merck) PROQUAD (lot # 1047307 and expiry date 23-MAY-2017). No adverse events were reported. No further information was available. Product quality complaint (PQC) was not involved. Additional information has been requested.
can only draw 9 full doses from each vial, always a little short of the tenth dose; Doses administered from vials that were underfilled (PC); This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT PACKAGING QUANTITY ISSUE (can only draw 9 full doses from each vial, always a little short of the tenth dose) and ACCIDENTAL UNDERDOSE (Doses administered from vials that were underfilled (PC)) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT PACKAGING QUANTITY ISSUE (can only draw 9 full doses from each vial, always a little short of the tenth dose) and ACCIDENTAL UNDERDOSE (Doses administered from vials that were underfilled (PC)). At the time of the report, PRODUCT PACKAGING QUANTITY ISSUE (can only draw 9 full doses from each vial, always a little short of the tenth dose) and ACCIDENTAL UNDERDOSE (Doses administered from vials that were underfilled (PC)) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Report receipt from QC is on 07-JAN-2021. PCID number is 5845. No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter.
I have tested positive today for Covid; I have tested positive today for Covid; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 65-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 25Jan2021 10:00AM (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient reported that he received other vaccines within 4 weeks prior to the COVID vaccine. The patient reported that he had tested positive today for covid on 24Mar2021 11:00. No treatment received for the adverse event. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 22Mar2021 (Test Name: pcr). Prior to vaccination, the patient was not diagnosed with COVID-19. The outcome of the events was unknown.   Information about batch/lot number has been requested.
Patient was seen 3/15/12 - complained his (R) shoulder & arm has been hurting since the injection. No swelling no redness} constant pain bicep head.
Approximately 6 hours post vaccination patient experienced spontaneous echymosis over ventral aspects of both hands---worse on thenar eminence.  Slightly painful to touch.  No other lesions noted and no other systemic symptoms with normal vital signs.  Lesions began to resolve about 18 hours after vaccination but were faintly apparent at 24 hours post vaccination.
pt rcvd vax; approx 2 hrs later pt exp severe generalized itching, nausea, headache & dizziness; pt devel rash; taken to ER & given injection of diphenhydramine; pt devel vomiting;
Numbness of the area where the vaccine was given, ganglion under the armpit, swelling from shoulder to chest, redness of the arm eventually and that goes down to the forearm.
Patient complained about vision not being clear; extremities shakiness and fainted for about 1 minute.
Fever of 104; Muscle ache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 15-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 24Sep2023 at 08:45 as dose number unknown (booster), single (Batch/Lot number: unknown) at the age of 15 years, in left arm for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), on 24Sep2023 at 08:45 as dose number unknown, single (Batch/Lot number: unknown), in right arm for immunisation. The patient's relevant medical history included: "congenital heart disease" (ongoing), notes: congenital heart disease open heart surgery when 1 year old; "open heart surgery" (ongoing), notes: congenital heart disease open heart surgery when 1 year old; "Asthma" (unspecified if ongoing). Concomitant medication(s) included: ALBUTEROL [SALBUTAMOL] taken for asthma (ongoing). Vaccination history included: Bnt162b2 (Primary Immunization series complete.), for COVID-19 immunization; Bnt162b2 (DOSE NUMBER UNKNOWN (BOOSTER), SINGLE), for COVID-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 24Sep2023, outcome "recovered" (25Sep2023), described as "Fever of 104"; MYALGIA (non-serious) with onset 24Sep2023, outcome "recovering", described as "Muscle ache". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia, myalgia.  Additional information: Yesterday they had gotten the vaccine and by bedtime around 9:00 PM/9:30 PM her son experienced a fever of 104 and really bad muscle aches. However, this morning when he woke up his temperature was 98 and he was fine. Treatment: Gave 650mg of Tylenol. Muscle Aches-It's milder now. It's to the point where he can go school. It was not debilitating or anything. Confirmed patient received the Pfizer booster shot for covid vaccine and she is speaking with them the pharmacy and informed there would be fewer side effects with the Pfizer brand vs the Moderna.   The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
77 year old vaccinated male was admitted with Covid-19 infection after he had been symptomatic for ~12 days. He was hyponatremic on admission. He was treated with Remdesivir and steroids. He developed DVT in LLE. He was in acute renal failure. His condition gradually declined. He was given empiric antibiotic. He was not a candidate for immunomodulator. He also developed a fib with RVR and CHF. He received rate control medications. He was on anticoagulation and later switched to NOAC. He became hypernatremic later during the stay. NGT was placed. He became dependent on BiPAP. His overall condition continued to deteriorate. Family made him comfort measures on 2/17 and he passed away on 2/17/2022 at 1835 hours.
Head Cold, swollen right parotid gland, stiff neck and general malaise. No fever.
Body aches, chills, fever starting evening of dose and continued through night.  Fever broke in the morning, less body aches but still sore. Injection site soreness as well.
her daughter coughed after receiving the vaccine; a 7-day-old patient received ROTATEQ; The staff member did not follow protocol/ Was the vaccine/vaccine-device used according to the instruction leaflet? No; Administered rotavirus vaccine to the newborn instead of the designated child; This spontaneous report has been received from a nurse, an office employee, and a consumer referring to a 7-day-old female patient. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies and concomitant therapies were not reported.   On 22-MAR-2022, according to the nurse and the office employee, the patient was administered 1 dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally (dose not reported; lot number 1742421 has been verified to be valid, expiration date reported as 17-DEC-2022, but upon internal verification was established as 07-DEC-2022) as prophylaxis (product administered to patient of inappropriate age).   On 22-MAR-2022, according to the patient's mother, the patient coughed after receiving the vaccine.   According to the office employee, the patient was being seen at the clinic for routine newborn follow up. A child with a similar name as the patient was ordered vaccines. The staff member did not follow the protocol (wrong technique in product usage process) and administered rotavirus vaccine, live, oral, pentavalent (ROTATEQ) to the patient, instead of the designated child (wrong patient received product). The child was monitored and had daily follow ups for three days. The office employee stated that no significant side effects occurred.   The outcome of cough was unknown. The causal relationship between the event and rotavirus vaccine, live, oral, pentavalent (ROTATEQ) was not provided.
She was found  to have a left femoral DVT and bilateral pulmonary emboli.  She was also  profoundly anemic.  She was put on Eliquis and iron.  She discontinued taking her  hormone and is now having significant vaginal bleeding.
This spontaneous report was received from a healthcare worker and refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' pertinent medical history, drug reaction or allergies was not reported. On an unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX (lot # L034370 with an expiration date 08-SEP-2017 and M002064 with an expiration date 12-JAN-2018) for prophylaxis (dose and route of administration were not reported). Concomitant therapies included sterile diluent (manufacturer unknown). Improperly stored vaccines underwent following temperature excursions: 25.6 F for 13 hours and 5.5 F for 1 hour. No symptoms were reported. There was no previous temperature excursion. Data logger was involved. Additional information has been requested.
Experienced Body aches, chills, headache, fatigue, malaise, heartburn - total duration 36 hours
chills; mild fever; This is a spontaneous report received from a contactable reporter(s) (Physician) from a sales representative.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, Single), for Covid-19 immunization, reaction(s): "Chills", "Fever"; Bnt162b2 (Dose 2, Single), for Covid-19 immunization, reaction(s): "Chills", "Fever"; Bnt162b2 (Dose 3 (Booster), Single), for Covid-19 immunization, reaction(s): "Chills", "Fever". The following information was reported: CHILLS (non-serious), outcome "recovered"; PYREXIA (non-serious), outcome "recovered", described as "mild fever". Additional information: Description of Event: Patient reports mild fever and chills for less than 24 hours after bivalent. States symptoms were less than with initial Covid-19 vaccine and previous booster.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
My daughter also had a histamine reaction, wish you made better product.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Covid" (unspecified if ongoing), notes: My entire family got COVID including my kids. The patient's concomitant medications were not reported. The following information was reported: HISTAMINE LEVEL INCREASED (non-serious), outcome "unknown", described as "My daughter also had a histamine reaction, wish you made better product.". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
t101.1 oral temp, pain redness, swollen from elbow up to deltoid muscle site of immun; was seen by MD in ER 1MAR93 was given Amoxicillin & adv heat compress;
Narrative: Patient received Moderna covid #1 on 4/1/21. On 4/6/21, he was contacted by agency and reported that all was well with him. Agency made other attempts to contact him on 5/7/21 and 5/13/21 and were unsuccessful. On 5/14/21, when they went to his apartment, they were notified that he was found deceased inside his apartment on 5/10/21. Only scanned records were from a orthopedic visit on 4/9/21 for bilateral knee pain and a dermatology visit on 4/20/21 for psoriasis and history of basal cell carcinoma. No notes to indicate what happened from time of vaccine to date of death (39 days). No autopsy report available.
DIZZY AND ALMOST LOST CONSCIOUSNESS, ANXIETY, SOB CHEST TIGHTNESS ...HR 92BPM, O2 SAT 94%, BP 156/118mmHg...
Information ha been received from a registered nurse concerning a 19 year old female who vaccinated intramuscularly with the third dose of the Gardasil on an unspecified date. Subsequently, the patient almost fainted and became extremely light-headed while at the physician's office. Subsequently, the patient recovered on the same day after receiving in the office. Additional information has been requested.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with ZOSTAVAX (dose, route and lot number were not reported). Concomitant medications were not reported. On an unknown date the patient had a reaction to ZOSTAVAX. The outcome of the reaction to ZOSTAVAX was not reported. The relationship between ZOSTAVAX and the event was related. Additional information has been requested.
Dizziness, Headache, Myalgia, NauseaVomiting, tinnitus Narrative:
It was painful to move my left arm starting Sunday afternoon 2/13/22. The pain lasted all week, each day able to do a little more with my arm but toward the end of the day it was extremely painful to move. I couldn?t lift my arm one day, then the next day I was able to lift it, but not able to lift if my arm was bent. The pain finally stopped on Friday 2/18/22. I tried taking ibuprofen to stop the pain throughout the week but it didn?t help.
During vaccination, there was a failure in the connection between the syringe needle and barrel. Some vaccine leaked out and down the patient's arm. After contacting the manufacturer (Moderna), I was informed that if the patient received more than half of the dose there is currently no need to revaccinate. I am confident that the patient received more than half of the dose so no further action was deemed necessary. The patient reported no adverse effects at this time.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A 37-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 31May2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 37 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset Jul2022, outcome "unknown", COVID-19 (medically significant) with onset Jul2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (27Jul2022) Negative; (31Jul2022) Faint Positive; (04Aug2022) strong positive. Therapeutic measures were taken as a result of covid-19.   Additional information: Paxlovid rebound-negative rapid tests on 27Jul and 31Jul followed by faint positive on 02Aug, recurrence of symptoms, strong positive on 04Aug, symptoms ongoing.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022; No adverse event; patient administered the vaccine after the 30 day by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient administered the vaccine after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 28-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 22-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient administered the vaccine after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient administered the vaccine after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (patient administered the vaccine after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022).    Concomitant medications were not reported.   Patient received full dose.  Administered the vaccine to 346 patients after the 30 day by used and total Number of vials was 35. The vial did not undergo any temperature excursions.  Treatment medications were not reported.
Patient had fevers of 103-105 degrees beginning on 3/27/2007 through 4/12/2007. The fever would be gone intermittently and then return within a few days.
Dizziness, diaphoresis, nausea. Lasted most of morning and early afternoon. No treatment sought.